Johnson & Johnson's innovative medicines division shows promise with expected revenues of $57bn by 2025. See more about JNJ ...

Johnson & Johnson (NYSE: JNJ) recently reported its Q3 results, with revenues and earnings exceeding our estimates.

Johnson & Johnson MedTech (NYSE: JNJ) today announced the first completed commercial case with its Varipulse platform in ...

Johnson & Johnson has been a stalwart dividend stock over the years because it has maintained a healthy financial profile, ...

RBC Capital raised the firm’s price target on Johnson & Johnson to $181 from $178 and keeps an Outperform rating on the ...

The FDA’s Suzanne Schwartz said at The Medtech Conference that addressing legacy devices is a “work in progress” and a problem that regulators and industry need to work on together.

The article " Johnson & Johnson Stock: Setting the Stage for 2025 Highs " first appeared on MarketBeat.

Medical device maker Intuitive Surgical beat Wall Street estimates for third-quarter profit on Thursday, helped by strong demand for its surgical robots used in minimally invasive procedures, sending ...

The CIO50 Awards program celebrates the achievements of the top senior technology and digital executives in Australia who are ...

All text, photos, graphics, artwork and other material on this site are copyrighted and may not be published, broadcast, rewritten or redistributed without permission.

India on Thursday weighed in on the ongoing diplomatic spat with Canada by holding the Trudeau administration responsible for 'precipitating' the current diplomatic fallout while acknowledging the ...

The Italian city of Turin, home to Europe's oldest car factory, typifies the industrial decay that parts of the continent face as its automakers struggle with the cost of electrification, low ...